| 439 |
413: Reduction, Testosterone synthesis in Leydig cells |
446: Reduction of testosterone |
Nov 29, 2016 |
Dec 2, 2016 |
None
|
| 2125 |
413: Reduction, Testosterone synthesis in Leydig cells |
1690: Decrease, circulating testosterone levels |
May 11, 2020 |
May 1, 2024 |
3 AOPs
|
| 2923 |
2139: Reduction, the ratio of E2/11-KT in plasma |
221: Reduction, Plasma vitellogenin concentrations |
May 22, 2023 |
May 22, 2023 |
1 AOP
|
| 3393 |
2139: Reduction, the ratio of E2/11-KT in plasma |
2137: Increase, Gonadotropins concentration in plasma |
Nov 16, 2024 |
Nov 16, 2024 |
1 AOP
|
| 337 |
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development |
78: Reduction, Cumulative fecundity and spawning |
Nov 29, 2016 |
Mar 20, 2017 |
9 AOPs
|
| 3396 |
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development |
1467: Growth, reduction |
Nov 16, 2024 |
Nov 16, 2024 |
1 AOP
|
| 315 |
285: Reduction, Vitellogenin synthesis in liver |
221: Reduction, Plasma vitellogenin concentrations |
Nov 29, 2016 |
Mar 20, 2017 |
7 AOPs
|
| 1081 |
1040: relaxation, smooth muscle |
1042: Proliferation/Clonal Expansion, smooth muscle |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1564 |
1426: Release of G Proteins |
1427: Opening of GIRK channels |
Jun 8, 2017 |
Jun 8, 2017 |
2 AOPs
|
| 1568 |
1426: Release of G Proteins |
1429: Inhibition of Ca Channels |
Jun 23, 2017 |
Jun 23, 2017 |
2 AOPs
|
| 108 |
87: Release, Cytokine |
149: Increase, Inflammation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 925 |
87: Release, Cytokine |
907: Infiltration, Inflammatory cytokines |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 994 |
87: Release, Cytokine |
901: Infiltration, Inflammatory cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1963 |
87: Release, Cytokine |
1497: Recruitment of inflammatory cells |
Jul 3, 2019 |
Jul 3, 2019 |
2 AOPs
|
| 2454 |
87: Release, Cytokine |
1914: Platelet activation, Increased |
Aug 4, 2021 |
Aug 4, 2021 |
1 AOP
|
| 2455 |
87: Release, Cytokine |
1915: Neutrophil activation, Increased |
Aug 4, 2021 |
Aug 4, 2021 |
1 AOP
|
| 3751 |
87: Release, Cytokine |
1263: Necrosis |
Mar 25, 2026 |
Mar 25, 2026 |
1 AOP
|
| 3752 |
87: Release, Cytokine |
1262: Apoptosis |
Mar 25, 2026 |
Mar 25, 2026 |
1 AOP
|
| 3753 |
87: Release, Cytokine |
2009: Activation, inflammation pathway |
Mar 25, 2026 |
Mar 25, 2026 |
1 AOP
|
| 1648 |
495: Repressed expression of steroidogenic enzymes |
413: Reduction, Testosterone synthesis in Leydig cells |
Aug 11, 2017 |
Aug 11, 2017 |
1 AOP
|
| 3615 |
495: Repressed expression of steroidogenic enzymes |
1690: Decrease, circulating testosterone levels |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3623 |
495: Repressed expression of steroidogenic enzymes |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Sep 3, 2025 |
Sep 3, 2025 |
None
|
| 2436 |
1902: Repression of Gbx2 expression |
1903: foxi1 expression, increased |
Jul 14, 2021 |
Aug 13, 2021 |
1 AOP
|
| 433 |
445: Respiratory distress/arrest |
351: Increased Mortality |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 592 |
445: Respiratory distress/arrest |
590: N/A, hypoxia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|